NOCIL Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹427 Cr +33% YoYSee revenue, profit and what management said. You are viewing Q4 FY26.
N

NOCIL

Q4 FY26Chemicals & Petrochemicals

NOCIL Q4 FY26: Capex ₹130 Cr

Q4 FY26 earnings call: what management said on revenue, margins and capex.

Revenue
₹330Cr
−2.9% YoY
+4.4% QoQ
Net profit
₹17Cr
−19% YoY
+88.9% QoQ
Margin
6%
−4 pp YoY
−2 pp QoQ
Price₹162
Market cap₹2.8K Cr
P/E40.1

The short version

NOCIL targets double-digit volume growth for FY '27 and FY '28. NOCIL targets double-digit volume growth for FY '27 and FY '28.

From NOCIL's Q4 FY26 earnings-call transcript · updated 25 Aug 2026.

Revenue & Sales Performance

  • NOCIL targets double-digit volume growth for FY '27 and FY '28. (Page 18)
  • Volume growth momentum picked up in H2 FY '26, expected to continue into FY '27. (Page 6)
  • New plant expansions and customer approvals anticipated to drive volume increase, with material capacity utilization improvements expected 6-8 months post-sample submission. (Page 14)
  • New products are in a pickup phase in FY '27; meaningful volume contribution expected gradually toward year-end. (Page 14)
  • Export volumes, especially in the USA market, are recovering post-duty adjustments, supporting growth. (Page 14)

2 more points from NOCIL's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what NOCIL said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Rs.130 crores capex focused largely on specialty segment, expected to be commissioned by FY '28, aiming to increase specialty product mix from ~15% to 20%. (Page 17)
  • Rs.250 crores capex at Dahej for incremental capacity expansion, increasing capacity by roughly 20%, targeting merchant sales. (Page 8 & 17)
  • The Rs.130 crores capex includes some intermediates and is largely for captive consumption, with part allocated to finished goods. (Page 8)
  • Capex largely internally funded through working capital efficiency without current debt borrowing, with bank lines available if needed at repo-linked rates. (Page 18)

2 more points from NOCIL's call on capex

Create a free account to keep reading this call

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
2Shiv Texchem
Rev 1Mar 2
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 1Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what NOCIL said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what NOCIL said on order book & pipeline — free account, 30 seconds.

NOCIL — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

NOCIL Q4 FY26 results — key figures

NOCIL Q4 FY26 reported results vs Q4 FY25, ₹ crore
₹ CrQ4 FY26Q4 FY25YoYQ3 FY26QoQ
Revenue330340-2.9%316+4.4%
Operating profit (EBITDA)2134-38.2%27-22.2%
Operating margin6%10%-4 pp8%-2 pp
Profit before tax2126-19.2%13+61.5%
Net profit (PAT)1721-19%9+88.9%
EPS (₹)1.021.24-17.7%0.55+85.5%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹427 Cr, net profit ₹24 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Indian Phosphate (Q4 FY26)

    H2 FY26 Revenue (Consolidated):** ₹580.25 Cr, up from ₹451.59 Cr in H2 FY25 — a year-on-year increase of ₹128.66 Cr. Key investor presentation takeaways from In

  • Paragon Fine (Q4 FY26)

    Revenue for H2FY26:** Rs 68.88 Cr, up 7.41% YoY from Rs 64.13 Cr in H2FY25 (Page 22). Key investor presentation takeaways from Paragon Fine's Q4 FY26 investor p

  • IVP (Q4 FY26)

    Q4 FY26 revenue from operations: ₹164.44 crore . Key investor presentation takeaways from IVP's Q4 FY26 investor presentation — and how it ranks against sector

  • Vishnu Chemicals (Q4 FY26)

    Q4 FY26 Operating Revenues: ₹450.3 crore, up 14.7% YoY from ₹392.6 crore in Q4 FY25 (Page 5). Key investor presentation takeaways from Vishnu Chemicals Ltd's Q4

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

NOCIL and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were NOCIL Q4 FY26 results?

NOCIL targets double-digit volume growth for FY '27 and FY '28. NOCIL targets double-digit volume growth for FY '27 and FY '28.

What is NOCIL share price analysis?

NOCIL currently shows a neutral. The stock trades at a P/E of 40.1 with a market cap of ₹2,790 Cr. Investors should review the full earnings analysis for detailed insights.

Is NOCIL planning capital expenditure?

Rs.130 crores capex focused largely on specialty segment, expected to be commissioned by FY '28, aiming to increase specialty product mix from ~15% to 20%.

Keep NOCIL on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.